Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Contract/Agreement, Product/Service

Acxiom and DeepIntent Introduce Direct Data Integration to Optimize Healthcare Marketing Reach, Impact, and Performance


Acxiom, the global leader in customer intelligence, today announced its strategic integration with DeepIntent, the healthcare advertising platform.

Healthcare brands, marketers, and agencies can use DeepIntent's Demand Side Platform (DSP) to directly access Acxiom's exclusive health interest audiences, detailed, HIPAA-compliant health-related interest data, and advanced analytics, increasing healthcare interest marketing campaign speed, engagement, and conversions.

Key Features Include:

Extended Benefits to Consumers and the Healthcare Industry:

"In an era where data-driven decisions are paramount, Acxiom and DeepIntent's integration not only accelerates our client's ability to deliver personalized health messages but also embodies our commitment to innovation and excellence," said Sean Muzzy, CEO of KINESSO. "Leveraging this cutting-edge platform, we can craft a future where every marketing interaction is an opportunity to positively impact patient health outcomes. Together, we are not just reaching audiences; we are touching lives and fostering a healthier world for all."

Chris Paquette, CEO of DeepIntent, added, "Recognizing the importance of partnerships, we've embraced an ?open architecture' approach that allows our partners to leverage their data assets and build solutions that more dynamically address our client's specific needs. Our partnership with Acxiom enhances our ability to serve Kinesso clients more effectively, allowing us to co-create and become the infrastructure for future healthcare solutions. This collaboration is pivotal as we continue to innovate and lead in delivering impactful healthcare advertising."

"We are thrilled to partner with DeepIntent and combine our collective strengths to redefine healthcare interest marketing," said Martin Wexler, SVP of Channel Partnerships at Acxiom. "This integration underscores our commitment to provide marketers with the advanced tools they need to amplify patient engagement and outcomes by ensuring crucial health information is accessible when and where it matters most."

About Acxiom

Acxiom® is the global leader in customer intelligence and stands at the forefront of AI- enabled, data-driven marketing. As part of the Interpublic Group of Companies, Inc. (IPG), we specialize in high-performance solutions that boost customer acquisition and retention while fueling growth for the world's biggest brands and agencies. We transform omnichannel marketing strategies and execution using our AI-powered data and identity foundation, cloud-based data management, and martech and analytics services. For over 55 years, our teams across the US, UK, Germany, China, Poland, and Mexico have helped businesses optimize their marketing and advertising investments while prioritizing customer privacy. Discover more at Acxiom.com, where marketing is made better.

About DeepIntent

DeepIntent leads health advertising into the future based on the core belief that advertising technology contributes measurably to positive health outcomes. Built purposefully for the healthcare industry, the DeepIntent Health Advertising Platform employs patented technology and the industry's most comprehensive health data to drive higher audience quality and script performance. 600+ pharmaceutical brands and all the leading healthcare agencies trust DeepIntent to reach the most relevant healthcare providers and patient audiences across all channels and devices. For more information, visit DeepIntent.com or find us on LinkedIn.


These press releases may also interest you

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...

at 06:07
Gotion High-tech hosted its 13th Technology Conference on May 17, unveiling its new products and new technology, including 5C ultra-fast charging G-Current battery ready for immediate mass production, high-nickel NCM cylindrical Stellary battery and...



News published on and distributed by: